Front Row Advisors LLC
- SEC CIK
- 0001729254
- Latest filing
- Aug 13, 2026
ABUS holding history
Arbutus Biopharma Corp in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABUS overviewAll 13F holders of ABUSFull Q2 2026 holdings
- Shares (Q2 2026)
- 110,500
- Value
- $516.0K
- % of portfolio
- 0.1%
- Quarters held
- 18
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 110,500 | $516.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 110,500 | $497.3K | 0.2% | +100,000+952.4% | Added | Holders |
| Q4 2025 | 10,500 | $50.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 10,500 | $47.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 10,500 | $32.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,500 | $36.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 10,500 | $34.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,500 | $40.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 10,500 | $32.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 10,500 | $27.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 10,500 | $26.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 10,500 | $21.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 10,500 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 10,500 | $32.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 10,500 | $24.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 10,500 | $20.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 10,500 | $28.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 10,500 | $31.0K | <0.1% | +10,500 | New | Holders |